[糖尿病中的β细胞] - Suppr

Suppr

超能文献

[The beta cell in diabetes].

作者信息

Lenzen S

机构信息

Institut für Klinische Biochemie, Medizinische Hochschule Hannover.

出版信息

Dtsch Med Wochenschr. 2011 May;136(21):1123-7. doi: 10.1055/s-0031-1280522. Epub 2011 May 17.

DOI:10.1055/s-0031-1280522

PMID:21590632

Abstract

摘要

相似文献

[The beta cell in diabetes].

Dtsch Med Wochenschr. 2011 May;136(21):1123-7. doi: 10.1055/s-0031-1280522. Epub 2011 May 17.

The key to glucose: a guide to the hormone (and protein) insulin.

Diabetes Forecast. 2011 Oct;64(10):32, 35.

Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.

Diabetes Metab. 2008 Feb;34 Suppl 2:S56-64. doi: 10.1016/S1262-3636(08)73396-2.

[Antibodies instead of insulin?].

Pharm Unserer Zeit. 2010 Mar;39(2):97-8. doi: 10.1002/pauz.201090017.

Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control.

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S178-83. doi: 10.2337/dc09-S306.

Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going.

Am J Med. 2010 Mar;123(3 Suppl):S38-48. doi: 10.1016/j.amjmed.2009.12.008.

Treatment of type 2 diabetes with combined therapy: what are the pros and cons?

Diabetes Care. 2008 Feb;31 Suppl 2:S131-5. doi: 10.2337/dc08-s233.

Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.

Metabolism. 2010 Jun;59(6):887-95. doi: 10.1016/j.metabol.2009.10.007. Epub 2009 Dec 16.

[How to explain the rebirth of the beta cell in terms of sacrifice and delivery].

Journ Annu Diabetol Hotel Dieu. 2007:171-9.

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

N Engl J Med. 2005 Jun 23;352(25):2598-608. doi: 10.1056/NEJMoa043980.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[The beta cell in diabetes].

Dtsch Med Wochenschr. 2011 May;136(21):1123-7. doi: 10.1055/s-0031-1280522. Epub 2011 May 17.

The key to glucose: a guide to the hormone (and protein) insulin.

Diabetes Forecast. 2011 Oct;64(10):32, 35.

Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.

Diabetes Metab. 2008 Feb;34 Suppl 2:S56-64. doi: 10.1016/S1262-3636(08)73396-2.

[Antibodies instead of insulin?].

Pharm Unserer Zeit. 2010 Mar;39(2):97-8. doi: 10.1002/pauz.201090017.

Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control.

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S178-83. doi: 10.2337/dc09-S306.

Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going.

Am J Med. 2010 Mar;123(3 Suppl):S38-48. doi: 10.1016/j.amjmed.2009.12.008.

Treatment of type 2 diabetes with combined therapy: what are the pros and cons?

Diabetes Care. 2008 Feb;31 Suppl 2:S131-5. doi: 10.2337/dc08-s233.

Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.

Metabolism. 2010 Jun;59(6):887-95. doi: 10.1016/j.metabol.2009.10.007. Epub 2009 Dec 16.

[How to explain the rebirth of the beta cell in terms of sacrifice and delivery].

Journ Annu Diabetol Hotel Dieu. 2007:171-9.

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

N Engl J Med. 2005 Jun 23;352(25):2598-608. doi: 10.1056/NEJMoa043980.